The Federal Trade Commission’s (FTCs) Bureau of Consumer Protection today announced the issuance of Health Products Compliance Guidance, the agency’s first revision of its business guidance in this area in nearly 25 years. One major revision is to extend the guidance covering dietary supplements to all health-related products.
The revised guide also reflects updates to other FTC guidance documents, including the guidance on endorsements and testimonials. Among other things, the new guide includes a much more detailed discussion of the amount and type of evidence needed to substantiate health-related claims, with more emphasis on the fact that the FTC, as a general rule, expects high quality randomized, controlled human clinical trials.
Recent Posts
Update on Hearing Device Services Codes
As released publicly in the March 10, 2026, AMA’s Errata & Technical Corrections CPT 2026, the parentheticals related to code 92628 (Evaluation for hearing candidacy)…
Intratympanic Steroid Therapy as a Salvage Treatment for Sudden Sensorineural Hearing Loss
Fernandez et al. (2026) completed a retrospective analysis of 86 patients seen between 2019 and 2024 with sudden sensorineural hearing loss (SSNHL). This analysis compared…
Clinical Superiority of Belly-Tendon Montage Over Others for Recording Air-Conducted Ocular Vestibular Evoked Myogenic Potential
In a recent study published by Raveendran and Singh (2026), a number of ocular vestibular evoked myogenic potential (oVEMP) electrode montages were compared. This study…


